ENOV DJO Global: Debts to Book Capitalization

Corporate company logo of Enovis Corp (ENOV)

The price history of Enovis Corporation (ENOV) reflects the dynamics of an asset whose pricing power is constrained by the influence of US group purchasing organizations, with the current indicator standing at 0.86. The business relies on capturing the high-tech surgery niche through acquisitions and expansion into Western markets. Simultaneously, the company is resisting pressure from corporate behemoths seeking to displace mid-sized manufacturers by acquiring promising startups.

Enovis Inc. - ENOV Debts to Net Assets (period 04/28/2023 - 10/30/2026)
Original product of Enovis Corp

This indicator measures the company's reliance on borrowed funds relative to its equity, allowing for an assessment of financial stability and the risk of debt load volatility. By analyzing the chart of the total debt-to-book capitalization ratio, an investor can gauge the funding reliability of Enovis Corporation (ENOV) high-tech developments in biomechanics and robotics, which is critical for retaining top talent within the stable healthcare sector.

Direct competitors

Debts to Book Capitalization BSX (Boston Scientific)|edwards.com (EW) - Debts to Book Value|ResMed - Debts to Book Capitalization|Insulet Corp (PODD) - Debt to Book Value|ZBH: Debts to Book Capitalization|COO - Debts to Net Assets|ALGN (Align Technology, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization globusmedical.com|Debt to Book Capitalization Ratio TransMedics Organ Care System (TMDX)|Debt to Book Capitalization Ratio ATEC (Alphatec Holdings)|Debts to Book Capitalization AORT (Artivion Inc)|Debts to Net Assets Integra LifeSciences Inc. (IART)|ESTA: Debt to Book Value|Debts to Book Capitalization Ratio BBNX|IRMD: Debts to Book Capitalization|Debts to Book Value Embecta Corp (EMBC)|TNDM (Tandem Diabetes) - Debts to Book Capitalization|Debt to Book Value Ratio AXGN (Axogen Surgical)|Debt to Book Value SIBN (SI-BONE, Inc.)|OFIX (orthofix.com) - Debt to Net Assets Ratio|Debt to Book Capitalization Ratio Bioventus BVS|KIDS - Debt to Book Value|Treace Medical - Debts to Book Capitalization|Debts to Book Value Strata Medical|CARL: Debts to Book Capitalization|Debt to Book Value Ratio RXST|CLPT (ClearPoint Neuro Inc.) - Debts to Book Capitalization|Stereotaxis Inc (STXS) - Debts to Net Assets|Debts to Book Capitalization STIM|Debt to Book Value Sight Sciences Inc SGHT|Debts to Book Capitalization OBIO (Orchestra BioMed, Inc.)|Debts to Book Capitalization Anika Therapeutics Inc. ANIK|NSPR - Debt to Book Capitalization Ratio|ZJYL: Debt to Book Capitalization Ratio|VANI (vivani.com) - Debt to Book Value|Xtant Medical - Debt to Net Assets Ratio|NMTC (NeuroOne Medical Technologies) - Debts to Book Capitalization|Debts to Book Value Modular Med MODD|Debt to Book Capitalization Ratio Myomo (MYO)|Envoy Medical Inc. (COCH) - Debt to Net Assets|Vivos Therapeutics, Inc - Debt to Book Value|Debts to Book Capitalization enVVeno Corp NVNO|SINTX Technologies - Debts to Book Capitalization|Debts to Net Assets tenonmed.com TNON|Lifeward (LFWD) - Debt to Book Capitalization Ratio|Debts to Book Capitalization Ratio AMIX (Autonomix Medical)|Debt to Book Capitalization Ratio INVO Bioscience, Inc.|Debt to Book Value Bone Biologics Inc (BBLG)|Debts to Book Capitalization AXNX|BIOL - Debts to Book Value|Debt to Book Capitalization Ratio Dynatronics DYNT|FNA: Debt to Book Value Ratio|INVO: Debt to Book Value